6 months of tirzepatide 30 lbs in on │ Here's What Actually Happens ✨ Tirzepatide patient — 6

Pediatrics 151(2):e2022060640 Singhal V, Sella AC, Malhotra S (2021) Pharmacotherapy in pediatric obesity: current evidence and landscape

Mechanistic models propose that MC1R activation by Melanotan 1 may elevate cyclic adenosine monophosphate levels, subsequently influencing microphthalmia associated transcription factor expression and the transcription of enzymes involved in eumelanin production

Treatment with semaglutide demonstrated sustained, statistically superior and clinically significant reductions in HbA1c and body weight for up to 2 years compared to placebo and active control treatment (sitagliptin, insulin glargine, exenatide ER and dulaglutide)

Reduced diabetes distress: As glycemic control improves, patients often experience reduced anxiety and stress related to managing their condition

Example: 0.125 mg every 2 weeks costs $75- $150 per month

Partially, and only for heart rate